A novel method for pharmacokinetic parameters quantification in DCE-MRI: Application in prostate cancer.
1/5 보강
[BACKGROUND] Detecting and quantifying tumor vascularity is critical for diagnosing cancer, guiding therapy, and monitoring disease progression.
APA
Aponte J, Ruíz Á, et al. (2026). A novel method for pharmacokinetic parameters quantification in DCE-MRI: Application in prostate cancer.. Medical physics, 53(1), e70229. https://doi.org/10.1002/mp.70229
MLA
Aponte J, et al.. "A novel method for pharmacokinetic parameters quantification in DCE-MRI: Application in prostate cancer.." Medical physics, vol. 53, no. 1, 2026, pp. e70229.
PMID
41549699 ↗
DOI
10.1002/mp.70229
Abstract 한글 요약
[BACKGROUND] Detecting and quantifying tumor vascularity is critical for diagnosing cancer, guiding therapy, and monitoring disease progression.
[PURPOSE] This study focuses on quantifying pharmacokinetic parameters derived from multi-compartment models by analyzing and processing dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data of prostate cancer lesions.
[METHODS] Previous voxel-based analysis employed the three-time-point method to classify different regions based on kinetic patterns. The key pharmacokinetic parameters-such as , the vascular elimination rate, and , the extravascular transfer rate, were extracted using a novel point-wise interpolation method designed for application in compartmental models.
[RESULTS] Results from the simple two-compartment model proposed by Brix revealed the presence of both fast and slow exchange regions, suggesting the potential for a more complex multi-compartment model. Parameter distribution maps generated from this analysis appear to correlate with pathological and unaffected glandular regions. Further investigation using a three-compartment model identified an additional exchange rate that lies between the previously observed fast and slow rates, supporting the assumption of tissue heterogeneity beyond the two-compartment framework.
[CONCLUSIONS] A simple two-compartment model can effectively describe the kinetics of contrast media. When combined with a novel voxel-wise method, it enables the estimation of tissue exchange parameters and their spatial distributions. These results have potential applications in the diagnostic evaluation and therapeutic monitoring of prostate cancer.
[PURPOSE] This study focuses on quantifying pharmacokinetic parameters derived from multi-compartment models by analyzing and processing dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data of prostate cancer lesions.
[METHODS] Previous voxel-based analysis employed the three-time-point method to classify different regions based on kinetic patterns. The key pharmacokinetic parameters-such as , the vascular elimination rate, and , the extravascular transfer rate, were extracted using a novel point-wise interpolation method designed for application in compartmental models.
[RESULTS] Results from the simple two-compartment model proposed by Brix revealed the presence of both fast and slow exchange regions, suggesting the potential for a more complex multi-compartment model. Parameter distribution maps generated from this analysis appear to correlate with pathological and unaffected glandular regions. Further investigation using a three-compartment model identified an additional exchange rate that lies between the previously observed fast and slow rates, supporting the assumption of tissue heterogeneity beyond the two-compartment framework.
[CONCLUSIONS] A simple two-compartment model can effectively describe the kinetics of contrast media. When combined with a novel voxel-wise method, it enables the estimation of tissue exchange parameters and their spatial distributions. These results have potential applications in the diagnostic evaluation and therapeutic monitoring of prostate cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.